Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients

Journal of Neuroimmunology, 05/25/2012

The CT+TT and HH genotypes had higher MMP–9 levels as compared to patients carrying the CC and LL. Drug therapy resistance, disease severity, MMP–9 plasma activity and polymorphisms are associated with multiple sclerosis (MS).

Print Article Summary Cat 2 CME Report